GLG News by Cubicin Prescribers (US)

These strategies are running out of steam as insurers, and even the general public, are catching on.  Most insurers will only pay for generic modafanil, and these new versions will not sell as much as they would have even 5 years ago.  The abuse potential of the drug may help, as brand-name...

The key point in this article is that the author shows a connection between Community Acquired clostridium difficile infections & lack of antimicrobial use. For example, the widespread use of ant-acids ie; proton pump inhibitors. This article is helpful because delineating some of the risk factors...

Because equivalent results were shown, there will be no change in stent placement volumes.

Hepcidine is a key regulator of iron balence. Despite the availability of some iron makers (ferritin, sideremia and transferrin), hepcidine dosage can aid in the interpretation of complex clinical cases. However, its use could be limited to very particular clinical cases.

we have known about the availability of this test for several months and have been using it even before the FDA recommendations or the recent guideline changes which also recommended it.This addresses to a great extent the issue surrounding HSR (hypersusceptibility reaction) which has kept some clinicians...

After the extensive studies published (Mallal et al), it becomes mandatory to perform a genetic HLA screening before starting abacavir-containing antiretroviral associations. Problems are recognizable in these points: - laboratories are not capable to front an exaggerated request of HLA typing; - ad-hoc...

The idea that people will always buy prescription and OTC drugs and will go to the physician and dentist, no matter what the economic conditions in the country, is, in my opinion, erroneous.  People's first priorities are getting to work (requiring gas), food, and shelter.  The most money...

Medicare will use a very small carrot to entice financially stressed physicians to employ electronic prescribing technology.  Later on, Medicare will switch to the stick and penalize physicians who don't use such a system.

Cuts in Medicare put off for the time being, though only under substantial political pressure.  This band-aid will last only so long; real reform of the flawed sustainable growth rate eludes us yet again!  Bush and friends still favor the insurance lobby over senior's access to their phys...

Drug makers complain that the FDA's 'safety focus' slows down their development of new medications.  They would love to see accelerated approvals; next they'll get the immunity from lawsuits that device makers have already received!